Pressed chromium-powder cyclotron targets were irradiated with 16 MeV protons, producing 52 Mn with average yields of 6.2 ± 0.8 MBq/µAh. Separation by solid-phase anion exchange from ethanol-HCl mixtures recovered 94.3 ± 1.7% of 52 Mn and reduced the chromium content by a factor of 2.2 ± 0.4 × 10 5 . An additional AG 1-X8 column was used to remove copper, iron, cobalt and zinc impurities from the prepared 52 Mn in 8 M HCl. The macrocyclic chelator DOTA was rapidly radiolabeled with 52 Mn in aq. ammonium acetate (pH 7.5 R.T.) with a radiochemical yield >98% within 1 minute and was stable for >2 days in bovine serum. The improved separation and purification methodology facilitates the use of 52 Mn in basic science and preclinical investigations.
Introduction
Manganese is an element essential to living organisms in which it functions as a co-factor in a wide variety of enzymes in its divalent state 2 . Mn 2+ enters neurons via voltage gated Ca 2+ channels and has, due to its paramagnetic properties, been used preclinically as a potent MRI contrast agent for imaging neural activity 3 .
In addition, it has been established that manganese enters active beta cells in the islets of Langerhans, thus providing the possibility of a non-invasive measure of the functional beta cell mass during the progression of diabetes 4 .
Manganese, however, is toxic and the maximum amount of injected MRI contrast is therefore severely limited [5] [6] [7] . This fact has hindered the use of manganese enhanced MRI (MEMRI) in clinical investigations.
However, the already well established methods developed in preclinical MEMRI can be readily adapted to Positron Emission Tomography (PET) by using 52g Mn (from here on 52 Mn, t ½ = 5.6 days; β + = 29.4%; E aveβ+ = 242 keV), for which sub-nM concentrations are sufficient for functional imaging, thereby completely bypassing the toxicity issues of manganese.
Currently 89 Zr and 64 Cu are the common radiometals of choice for labeling proteins with slow distribution kinetics 8, 9 . However, for some preclinical and basic science applications 52 Mn may be a better choice. It provides aqueous chelation chemistry similar to that of 64 Cu, omitting the need for hard ligands like oxalate which are needed to keep 89 Zr chemically accessible, while having a higher β + branch as well as a longer half-life than both 64 Cu (17.6% β + , T ½ = 12.7 h) and 89 Zr (22.7% β + , T ½ = 3.3 days). In PET imaging of small animals, image resolution is a critical in order to allow discrimination of different regions of interest. The primary factor limiting the resolution is the energy of the emitted positron 10 . In principle, the lower average β + energy of 52 Mn (242 keV for 52 Mn versus 396 keV for 89 Zr) will result in PET resolution superior to 89 Zr.
Despite its facile chelation chemistry and attractive imaging properties, limited work has been reported on the separation chemistry and labeling with 52 Mn. This is probably a consequence of the somewhat discouraging dosimetry associated with the multiple high energy, high abundance gamma emissions of 52 Mn (744, 936 and 1434 keV) as seen in figure 1. This, however, only has significance if the purpose of the study is translational tracer design. In drug development, the dosimetry is less relevant, because the radioisotope is not intended to be part of the final drug product, but only used as a means to gather crucial information about drug kinetics, biodistribution, route of metabolization and excretion, etc. Detailed work on production cross-sections of the nat Cr(p,x) 52 Mn reaction has demonstrated that the reaction is highly capable of providing sufficient amounts of 52 Mn for imaging applications 12, 13 . Recently, Buchholz et al. reported a separation method based on solid phase extraction of manganese from acid/organic solvent mixtures 14 . The results presented in the present study are an improvement on a conceptually similar method recently published by this group 1 , demonstrating improved separation efficiency without compromising the decrease in chromium content. One major improvement on previously published work is the introduction of a remediation column, which efficiently removes non-radioactive metal-ion impurities that would otherwise hinder high specific activity labeling. The improved method is still time efficient and can be performed in less than 4 h. Additionally, optimized labeling conditions with the chelator DOTA (1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid) The work presented in this paper describes tested and optimized procedures for production and purification, as well as labeling with 52 Mn produced on a small medical cyclotron.
Materials and Methods

General experimental details
Unless otherwise stated, all chemicals were purchased from Sigma Aldrich. Chromium powder (100 -325 mesh, 99.99% purity) was obtained from Alfa-Aesar. Hydrochloric acid (aq. HCl ≥ 37%, TraceSelect, Fluka) was titrated and found to be 11.3 M. All other concentrations of HCl used, were prepared from this batch by dilution with TraceSELECT water (Fluka). All other water was Milli-Q grade (Sartorius Arium 611VF, σ = 0.055 µS/cm). 
Cyclotron targetry and irradiation
The targets were prepared by pressing 90-273 mg of chromium powder onto the surface of a 1 mm thick Ø = 29 mm silver disc using a metal powder pressing mold, ensuring centering of the Ø = 13 mm pressed chromium pellets. The pressing was done using a mechanical press at 7500 kg/cm 2 of pressure (10000 kg, Ø = 13 mm) resulting in approximate target thicknesses in the range of 68-206 mg/cm 2 . The disc was covered with an either 12.5 µm or 25 µm niobium front foil and mounted on a beam port on a GE PETtrace 800 cyclotron, providing direct water cooling on the rear face of the silver disc. The target was irradiated at a beam current of 20 µA with an incident energy of 16 MeV for 80-400 minutes resulting in integrated currents of 28-128 µAh. 52 Mn was produced primarily via the 52 Cr(p,n) 52 Mn reaction, with a small contribution from the less abundant 53 Cr via 53 Cr(p,2n) 52 Mn, by proton irradiation of naturally abundant chromium. The 2.36% abundant 54 Cr gave rise to co-production of small amounts of 54 Mn via the 54 Cr(p,n) 54 Mn reaction.
Determination of separation conditions
In order to determine the optimal acid:ethanol ratio for selective solid phase extraction of manganese from chromium onto AG 1-X8 resin, distribution coefficients of Cr 3+ and Mn 2+ on AG 1-X8 were determined in mixtures of aqueous HCl (conc. range: 3.8-11.3 M) and absolute ethanol, mixed in a range of 2-7% (v/v) aq.
HCl in ethanol. A total of 18 different conditions were tested by adding 100 ± 2 mg of AG 1-X8 resin to 5 mL of each of the acid:ethanol ratios, all containing 100 kBq 52 Mn and 250 µg nat Cr. The resulting mixtures were agitated periodically over the course of several hours at room temperature, and after settling for 72 h they were re-agitated and finally allowed to settle for a further hour. 100 µL samples of the supernatants were removed for measurement by ICP-OES to determine the Cr-content and liquid scintillation counting to determine the 52 Mn content. The data were analyzed by comparison to Cr and 52 Mn containing standards prepared without resin.
Separation
Following bombardment, the irradiated target was left on the cyclotron for at least 2 hours to allow the decay of 52m Mn (t 1/2 = 20 min). After disassembling the target holder, the target disc was submerged in 11.3 M HCl and either left overnight at room temperature or on a heating block at 90-100 ˚C for approx. 30 min to dissolve the chromium. The entire dissolution was taken almost to dryness at 150 ˚C (either with or without nitrogen flow) and redissolved in aq. HCl (1. 
Trace Metal Content and Remediation
After each separation repetition, samples were taken for ICP-OES analysis to determine the separation efficiency. The analytical concentrations of chromium and manganese were determined, as well as the common impurities iron, copper, cobalt, and zinc. 50 µL or 100 µL of sample material were diluted to 5-10 mL with 0.3 M HCl in 15 mL metal free PP centrifuge tubes (VWR) before analysis. The separation efficiency was determined from the calculated chromium content. The specific activity was calculated using the Mn content as determined by ICP-OES.
As contaminant metals will vary depending on target material and reagent stocks, we implemented a short procedure for removal of the unwanted metal ions of iron, zinc, copper, and cobalt. For this procedure, a sample of 52 Mn (in 0.1M HCl) from after the third separation column, was dried down and then redissolved in 1 mL 8 M HCl. This was passed over 500 mg AG 1-X8 resin (pre-equilibrated in 8 M HCl) and the effluent containing the 52 Mn, along with a wash volume of an additional 2 mL of 8 M HCl, were collected and the metal content determined using ICP-OES. After incubation at 37 ˚C for 2 days, the mixtures were applied to PD-10 size exclusion cartridges (GE Healthcare), eluted with isotonic HEPES and collected in 1 mL fractions. The radioactivity in the collected fractions was measured, and the peak fractions from the DOTA-containing samples were analyzed by radio-TLC to assess whether the Mn-DOTA complex was still intact.
Results
Cyclotron targetry and irradiation
None of the irradiated targets showed visible signs of thermal damage after irradiation. The production yields for 52 Mn ranged from 4.87-7.43 MBq/µAh, while 51 Cr production rates ranged from 0.29-0.39 MBq/µAh.
Considering that 52m Mn has a very short half-life and that 51 Cr is separated along with the bulk nat Cr, the only isotope that could appear as a contaminant after purification is 54 Mn (T ½ = 312.1 days), which was produced at an approximate rate of 7.4 kBq/µAh.
Determination of separation conditions
Batch mode experiments were performed to determine the distribution coefficients of both Mn 2+ and Cr 3+ on the anion exchange resin AG 1-X8 in a range of 2-7% (v/v) 3.8-11.3 M HCl in absolute ethanol (figure 2).
The measurements revealed an increase in Mn 2+ extraction with increasing ethanol concentration as well as with increasing molarity of the acid. Under many of the conditions sampled, the measured distribution coefficient of manganese exceeded 1000 mL/g, which is sufficiently high to design trap-and-release extraction on small resin beds. The results showed a slight up-concentration of Cr 3+ to the solid phase from the solvent mixture, but always in a range of 0.5-10 mL/g (figure 2). 
Separation
Dissolution of the chromium target in 11.3M HCl was very slow at room temperature, but was greatly accelerated with heat. Depending on laboratory logistics for the experiments, target dissolutions were either heated or not, with no observed disruption of the further chemical separation. Drying the dissolved target was time consuming, but was accelerated with nitrogen gas flow. The main purpose of drying the target was to obtain a reproducible acid and water content in the separation, and was found necessary to keep the processing volume small. It was important at this step not to dry the target material entirely, but to retain it as sludge in order to hasten redissolution. Redissolution with 11.3 M HCl was aided by heat, and at the first step was >99.5% efficient at re-suspending the 52 Mn radioactivity. In preliminary experiments, attempts were made to redissolve the dry target mass directly in 3% (v/v) 11.3M HCl in absolute ethanol, but this proved unsuccessful.
In the three repetitions of the AG 1-X8 purification, trapping of 52 Mn on AG 1-X8 was quantitative, with >99.8% of the available activity present on the column after washing. The 52 Mn was efficiently eluted (>97%) in 2 mL of 0.1 M HCl. After this, the 52 Mn-containing solution was dried down in order to reset the acid and water content. The largest losses of 52 Mn were incurred when attempting to re-solubilize the residue, ranging from 0.5-2% losses at each of the two repetitions. Similar to the previous redissolution, we found that dissolution of dried down Cr/Mn, was sufficiently efficient in hot 11.3 M HCl, but not possible in 3% (v/v) 11.3 M HCl in absolute ethanol. 94.3 ± 1.7% of the produced activity was retained after the three purification iterations, with an average Cr 3+ mass reduction factor of 2.2 ± 0.4 × 10 5 to an average mass of only 607 ng, as determined by ICP-OES (figure 3). Figure 3 : Reduction of the chromium content throughout the separation procedure (n=3). Chromium content is given as chromium mass per unit activity of 52 Mn, relative to the starting value. Therefore, the value shown on the plot for each step is the cumulative decontamination factor at the end of that step.
Trace Metal Content and Remediation
The specific activity of 52 Mn versus non-radioactive manganese content ranged from 16 to 120 GBq/µmol. ICP-OES analysis was able to determine which metal impurities were able to follow manganese through the purification steps. Other than chromium, the main impurities observed by ICP-OES analysis were iron and copper along with zinc and cobalt. These were present in varying amounts on the order of 0.01-1 nmol of each per MBq of 52 Mn, and could be removed by a final remediation step, in which the 52 Mn in 8 M HCl was passed over an AG 1-X8 column. As a result of this step, 17% of the 52 Mn remained on the AG 1-X8 column, while the remaining 83% was available for further use from the 8 M HCl. with the large molecule fractions, while when in buffer will elute with the small molecule fractions. 52 Mn dislocated from DOTA would elute in that manner, but that is not observed proving that the 52 Mn-DOTA complex is intact.
Discussion
The methodology developed above is optimized for recovery of 52 Mn in a small volume of dilute HCl. Improvements in 52 Mn extraction from the Cr matrix were made by employing sequentially smaller AG 1-X8 resin masses, using a controlled flow rate, and eluting in 0.1M HCl. Although the residual Cr 3+ content in the final product is slightly higher compared to Graves et al. (reduction factor of 2.2 ± 0.4 × 10 5 compared to 1.6 ± 1.0 × 10 6 ), the amount is still sufficiently below toxic levels 1 . Overall, trap and release of avoided by eluting the columns with a higher concentration of HCl, this would lead to excessively large volumes of ethanol/HCl needed for further processing.
Overall, the column behavior agrees well with the measured distribution coefficients. The highest distribution coefficients for Mn 2+ were observed at 2% (v:v) 11.3 M HCl in absolute ethanol with values of 1.06 × 10 4 mL/g. However, for the separation process, we selected 97% ethanol, because it afforded a more easy to handle volume of HCl for redissolving the dried 52 Mn, while still keeping the required ethanol volume below 10 mL for the second and third separations. Also evident in the Mn distribution coefficients is a strong dependence on the HCl concentration, but given the overall high values for 97% ethanol with 7.5 and 11.3 M HCl, the exact acid concentration seems to be unimportant. The behavior of Cr 3+ in this system was shown to be relatively independent of the acid and ethanol concentrations. Contaminant metal ions of copper, zinc, cobalt and iron were observed to follow manganese through the separation process, but these were easily removed by a final cleanup step of passing the collected 52 Mn over an AG 1-X8 resin bed in 8 M aq. HCl. In instances where bioconjugate chelation can be subverted by competing metals, this extra step may prove essential.
Chelation reactions with DOTA were rapid over a wide pH range (4.5-7.5) when DOTA was present in large excess, and Mn-DOTA was shown to be 100% stable in bovine serum for >2 days. DOTA furthermore has very low affinity for Cr 3+ , which makes 52 Mn chelation with DOTA insensitive to residual trace Cr after separation. These three points support the use of DOTA as a chelator for stable chelation and bioconjugation of 52 Mn to long-circulating tracing vectors.
Conclusion:
The separation method for purifying 52 Mn from bulk chromium presented in this paper is robust, efficient, and easily adaptable depending upon need. Radiolabeling with the common bioconjugate chelator DOTA is rapid and serum stability of the DOTA chelate is excellent, making 52 Mn useful for extended time-point PET imaging for drug development and pharmacokinetic evaluations.
